HIV vaccine trials:: Reconsidering the therapeutic misconception and the question of what constitutes trial related injuries

被引：4
|
作者：
Schueklenk, Udo
Ashcroft, Richard
机构：
来源：
DEVELOPING WORLD BIOETHICS | 2007年 / 7卷 / 03期
关键词：
D O I：
10.1111/j.1471-8847.2007.00210.x
中图分类号：
B82 [伦理学（道德学）];
学科分类号：
摘要：
引用
收藏
页码：II / IV
页数：3
相关论文
共 50 条
  • [41] Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
    Poole, D.
    Tracy, K.
    Levitz, L.
    Yekta, S.
    Kossow, E.
    Huang, T.
    Rochas, M.
    Sangare, K.
    Tounkara, K.
    Aboubacar, B.
    Koita, O.
    Diallo, F. Siby
    Sow, S.
    Teguete, I.
    Dolo, A.
    Bougoudogo, F.
    Lurie, M.
    De Groot, A. S.
    RETROVIROLOGY, 2012, 9
  • [42] Knowledge/attitude/practices of HPV & cervical cancer, willingness to participate in vaccine trial in preparation for HIV & HPV vaccine trials in Mali
    D Poole
    K Tracy
    L Levitz
    S Yekta
    E Kossow
    T Huang
    M Rochas
    K Sangare
    K Tounkara
    B Aboubacar
    O Koita
    F Siby Diallo
    S Sow
    I Téguété
    A Dolo
    F Bougoudogo
    M Lurie
    AS De Groot
    Retrovirology, 9
  • [43] Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial
    Sheon, AR
    Wagner, L
    McElrath, MJ
    Keefer, MC
    Zimmerman, E
    Israel, H
    Berger, D
    Fast, P
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 19 (05): : 519 - 526
  • [44] Using Clinical Trials Quality Management Model of China CIPRA for HIV Vaccine Clinical Trial in China
    Zhu, H.
    Zhang, J.
    Shao, Y.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 107 - 107
  • [45] The Results of Phase II Clinical Trial of Therapeutic HIV DNA Vaccine: The Possible Reach of Viral Reservoirs
    Akulova, Ekaterina
    Makashov, Andrei
    Matyunina, Ekaterina
    Verevochkin, Sergey
    Al-Shekhadat, Ruslan
    Masharsky, Alexey
    Poddubnyy, Valeriy
    Zozulya, Olga
    Vostokova, Natalia
    Kozlov, Andrey
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 390 - 390
  • [46] Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial
    Li, Jonathan Z.
    Brumme, Zabrina L.
    Brumme, Chanson J.
    Wang, Hongying
    Spritzler, John
    Robertson, Michael N.
    Lederman, Michael M.
    Carrington, Mary
    Walker, Bruce D.
    Schooley, Robert T.
    Kuritzkes, Daniel R.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (07): : 976 - 983
  • [47] International clinical trials of HIV vaccines .1. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand
    Phanuphak, P
    Teeratakulpixarn, S
    Sarangbin, S
    Nookhai, S
    Ubolyam, S
    Sirivichayakul, S
    Leesavan, A
    Forrest, BD
    Hanson, CV
    Li, ML
    Wang, CY
    Koff, WC
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 1997, 15 (01): : 41 - 48
  • [48] Pulmonary Infection Caused by Mycobacterium malmoense in a Chronic HIV-Infected Individual Participating in a Therapeutic Vaccine Trial
    Silva Marques, Joana
    Bodro, Marta
    Torres, Berta
    Garcia, Felipe
    Antonio Martinez, Jose
    Leal, Lorna
    VACCINES, 2021, 9 (10)
  • [49] Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial
    Goebel, FD
    Mannhalter, JW
    Belshe, RB
    Eibl, MM
    Grob, PJ
    de Gruttolae, V
    Griffiths, PD
    Erfle, V
    Kunschak, M
    Engl, W
    AIDS, 1999, 13 (12) : 1461 - 1468
  • [50] Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial
    Palich, Romain
    Ghosn, Jade
    Chaillon, Antoine
    Boilet, Valerie
    Nere, Marie-Laure
    Chaix, Marie-Laure
    Delobel, Pierre
    Molina, Jean-Michel
    Lucht, Frederic
    Bouchaud, Olivier
    Rieux, Veronique
    Thiebaut, Rodolphe
    Levy, Yves
    Delaugerre, Constance
    Lelievre, Jean-Daniel
    AIDS, 2019, 33 (02) : 279 - 284
12345